# A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035

> **NCT02690142** · PHASE1 · COMPLETED · sponsor: **Affibody** · enrollment: 72 (actual)

## Conditions studied

- Psoriasis
- Healthy Subjects

## Interventions

- **DRUG:** Placebo
- **DRUG:** ABY-035 i.v.
- **DRUG:** ABY-035 s.c.

## Key facts

- **NCT ID:** NCT02690142
- **Lead sponsor:** Affibody
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-01-10
- **Final completion:** 2018-01-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2018-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02690142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02690142, "A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02690142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*